Serum glucose level-dependent and independent modulation of μ-opioid agonist-mediated analgesia in diabetic mice
- 31 December 1993
- journal article
- Published by Elsevier in Life Sciences
- Vol. 52 (1) , 53-60
- https://doi.org/10.1016/0024-3205(93)90288-e
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermatesLife Sciences, 1988
- C57BL/6J-bg J (beige) mice: Differential sensitivity in the tail flick test to centrally administered MU- and delta-opioid receptor agonistsLife Sciences, 1987
- Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic ratsDiabetes, 1986
- Modification of morphine antinociceptive response by blood glucose status: Possible involvement of cellular energeticsEuropean Journal of Pharmacology, 1983
- An o-Toluidine Method for Body-Fluid Glucose DeterminationClinical Chemistry, 1962